BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salazar-Ramiro A, Ramírez-Ortega D, Pérez de la Cruz V, Hérnandez-Pedro NY, González-Esquivel DF, Sotelo J, Pineda B. Role of Redox Status in Development of Glioblastoma. Front Immunol 2016;7:156. [PMID: 27199982 DOI: 10.3389/fimmu.2016.00156] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Obukhova LM, Evdokimov II, Medyanik IA, Orlinskaya NY, Grishin AS, Babintsev VE, Barinov YA, Kontorshchikov MM, Gorshkova TN, Lazukin VF. Prospects for the use of blood elemental status to assess the molecular genetic profile of gliomas. Klin lab diagn 2022;67:497-503. [DOI: 10.51620/0869-2084-2022-67-9-497-503] [Reference Citation Analysis]
2 Basilico B, Palamà IE, D’amone S, Lauro C, Rosito M, Grieco M, Ratano P, Cordella F, Sanchini C, Di Angelantonio S, Ragozzino D, Cascione M, Gigli G, Cortese B. Substrate stiffness effect on molecular crosstalk of epithelial-mesenchymal transition mediators of human glioblastoma cells. Front Oncol 2022;12:983507. [DOI: 10.3389/fonc.2022.983507] [Reference Citation Analysis]
3 Costa AK, Marqueze LFB, Gattiboni BB, Pedroso GS, Vasconcellos FF, Cunha EBB, Justa HC, Baldissera AB, Nagashima S, de Noronha L, Radak Z, Fernandes LC, Pinho RA. Physical Training Protects Against Brain Toxicity in Mice Exposed to an Experimental Model of Glioblastoma. Neurochem Res 2022. [PMID: 35904698 DOI: 10.1007/s11064-022-03685-y] [Reference Citation Analysis]
4 Senhaji N, Squalli Houssaini A, Lamrabet S, Louati S, Bennis S. Molecular and Circulating Biomarkers in Patients with Glioblastoma. Int J Mol Sci 2022;23:7474. [PMID: 35806478 DOI: 10.3390/ijms23137474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kaushal P, Zhu J, Wan Z, Chen H, Ye J, Luo C. Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species. Neuromolecular Med 2022. [PMID: 35779207 DOI: 10.1007/s12017-022-08719-w] [Reference Citation Analysis]
6 Riaz S, Hussain I, Ibrahim M, Ishtiaq M, Ali Q, Muazzam Ali M, Sajid Hamid Akash M. Extraction and Optimization of Active Metabolites From Cluster Bean: An In Vitro Biological and Phytochemical Investigation. Dose-Response 2022;20:155932582210989. [DOI: 10.1177/15593258221098992] [Reference Citation Analysis]
7 Ferreira WAS, Vitiello GAF, da Silva Medina T, de Oliveira EHC. Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas. Sci Rep 2022;12:6442. [PMID: 35440701 DOI: 10.1038/s41598-022-10114-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Öcal Ö, Nazıroğlu M. Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells. Chem Biol Interact 2022;:109914. [PMID: 35395232 DOI: 10.1016/j.cbi.2022.109914] [Reference Citation Analysis]
9 Ji D, Luo ZW, Ovcjak A, Alanazi R, Bao MH, Feng ZP, Sun HS. Role of TRPM2 in brain tumours and potential as a drug target. Acta Pharmacol Sin 2022;43:759-70. [PMID: 34108651 DOI: 10.1038/s41401-021-00679-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Behl T, Gupta A, Chigurupati S, Singh S, Sehgal A, Badavath VN, Alhowail A, Mani V, Bhatia S, Al-Harrasi A, Bungau S. Natural and Synthetic Agents Targeting Reactive Carbonyl Species against Metabolic Syndrome. Molecules 2022;27:1583. [PMID: 35268685 DOI: 10.3390/molecules27051583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Majuelos-Melguizo J, Rodríguez-Vargas JM, Martínez-López N, Delgado-Bellido D, García-Díaz Á, Yuste VJ, García-Macía M, López LM, Singh R, Oliver FJ. Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization. Cancers (Basel) 2022;14:726. [PMID: 35158994 DOI: 10.3390/cancers14030726] [Reference Citation Analysis]
12 Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Aoki I, Obata T, Higashi T, Bakalova R. Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers 2022;14:485. [DOI: 10.3390/cancers14030485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ostrowski RP, Pucko EB. Harnessing oxidative stress for anti-glioma therapy. Neurochem Int 2022;:105281. [PMID: 35038460 DOI: 10.1016/j.neuint.2022.105281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ojha R, Tantray I, Rimal S, Mitra S, Cheshier S, Lu B. Regulation of reverse electron transfer at mitochondrial complex I by unconventional Notch action in cancer stem cells. Developmental Cell 2022;57:260-276.e9. [DOI: 10.1016/j.devcel.2021.12.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 Deshpande RP, Babu PP. Reactive Oxygen Species in Glioma. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_145] [Reference Citation Analysis]
16 Deshpande RP, Babu PP. Reactive Oxygen Species in Glioma. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_145-1] [Reference Citation Analysis]
17 Szeliga M. Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma. Neurochem Int 2021;:105256. [PMID: 34968631 DOI: 10.1016/j.neuint.2021.105256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wilms C, Lepka K, Häberlein F, Edwards S, Felsberg J, Pudelko L, Lindenberg TT, Poschmann G, Qin N, Volbracht K, Prozorovski T, Meuth SG, Kahlert UD, Remke M, Aktas O, Reifenberger G, Bräutigam L, Odermatt B, Berndt C. Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism. Redox Biol 2021;49:102221. [PMID: 34952462 DOI: 10.1016/j.redox.2021.102221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mehrabani N, Vaezi Kakhki MR, Javid H, Ebrahimi S, Hashemy SI. The SP/NK1R System-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin Protein. Neurol Res Int 2021;2021:9966000. [PMID: 34917417 DOI: 10.1155/2021/9966000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Morás AM, Henn JG, Steffens Reinhardt L, Lenz G, Moura DJ. Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma. Life Sci 2021;287:120128. [PMID: 34774874 DOI: 10.1016/j.lfs.2021.120128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Chuang HY, Hsu LY, Pan CM, Pikatan NW, Yadav VK, Fong IH, Chen CH, Yeh CT, Chiu SC. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis. Int J Mol Sci 2021;22:10247. [PMID: 34638586 DOI: 10.3390/ijms221910247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Yuan X, Wang L, Hu M, Zhang L, Chen H, Zhang D, Wang Z, Li T, Zhong M, Xu L, Wang D, Liu Y, Tan W. Oxygen Vacancy‐Driven Reversible Free Radical Catalysis for Environment‐Adaptive Cancer Chemodynamic Therapy. Angewandte Chemie 2021;133:21111-21119. [DOI: 10.1002/ange.202107556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Mazurek M, Rola R. The implications of nitric oxide metabolism in the treatment of glial tumors. Neurochem Int 2021;150:105172. [PMID: 34461111 DOI: 10.1016/j.neuint.2021.105172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Turkez H, Tozlu OO, Arslan ME, Mardinoglu A. Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies. Neurochem Int 2021;150:105168. [PMID: 34450218 DOI: 10.1016/j.neuint.2021.105168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yuan X, Wang L, Hu M, Zhang L, Chen H, Zhang D, Wang Z, Li T, Zhong M, Xu L, Wang D, Liu Y, Tan W. Oxygen Vacancy-Driven Reversible Free Radical Catalysis for Environment-Adaptive Cancer Chemodynamic Therapy. Angew Chem Int Ed Engl 2021;60:20943-51. [PMID: 34137148 DOI: 10.1002/anie.202107556] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
26 An JM, Ju Y, Kim JH, Lee H, Jung Y, Kim J, Kim YJ, Kim J, Kim D. A metastasis suppressor Pt-dendrimer nanozyme for the alleviation of glioblastoma. J Mater Chem B 2021;9:4015-23. [PMID: 33954328 DOI: 10.1039/d1tb00425e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
27 Gran ER, Lotocki V, Zhang Q, Antel J, Kakkar A, Maysinger D. Human astrocytes and astrocytoma respond differently to resveratrol. Nanomedicine 2021;37:102441. [PMID: 34302989 DOI: 10.1016/j.nano.2021.102441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jaganjac M, Cindrić M, Jakovčević A, Žarković K, Žarković N. Lipid peroxidation in brain tumors. Neurochem Int 2021;149:105118. [PMID: 34197897 DOI: 10.1016/j.neuint.2021.105118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
29 Orlicka-Płocka M, Fedoruk-Wyszomirska A, Gurda-Woźna D, Pawelczak P, Krawczyk P, Giel-Pietraszuk M, Framski G, Ostrowski T, Wyszko E. Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants (Basel) 2021;10:950. [PMID: 34204594 DOI: 10.3390/antiox10060950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
30 Behl T, Sharma A, Sharma L, Sehgal A, Singh S, Sharma N, Zengin G, Bungau S, Toma MM, Gitea D, Babes EE, Judea Pusta CT, Bumbu AG. Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme. Cancers (Basel) 2021;13:2765. [PMID: 34199460 DOI: 10.3390/cancers13112765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
31 Alghamri MS, McClellan BL, Hartlage MS, Haase S, Faisal SM, Thalla R, Dabaja A, Banerjee K, Carney SV, Mujeeb AA, Olin MR, Moon JJ, Schwendeman A, Lowenstein PR, Castro MG. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Front Pharmacol 2021;12:680021. [PMID: 34084145 DOI: 10.3389/fphar.2021.680021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
32 Dasgupta B, Hirota Y, Fujii Y, Osaka N, Ito D, Plas DR, Sasaki AT. Targeting Energy Metabolism to Overcome Therapeutic Resistance of Glioblastoma and Tumor-associated Edema. In: Debinski W, editor. Gliomas. Exon Publications; 2021. pp. 121-38. [DOI: 10.36255/exonpublications.gliomas.2021.chapter7] [Reference Citation Analysis]
33 Sengupta S, Pater LE, Krummel DP, Aronow BJ, Hirota Y, Phoenix TN, Sasaki AT. Integration of Molecular Analysis, Cutting-edge Mouse Genetic Models and Proton Therapy to Improve Outcomes for Glioma Patients. In: Debinski W, editor. Gliomas. Exon Publications; 2021. pp. 79-96. [DOI: 10.36255/exonpublications.gliomas.2021.chapter5] [Reference Citation Analysis]
34 Quero J, Mármol I, Cerrada E, Rodríguez-Yoldi MJ. Insight into the potential application of polyphenol-rich dietary intervention in degenerative disease management. Food Funct 2020;11:2805-25. [PMID: 32134090 DOI: 10.1039/d0fo00216j] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 28.0] [Reference Citation Analysis]
35 Kar F, Kacar S, Hacioglu C, Kanbak G, Sahinturk V. Concanavalin A induces apoptosis in a dose-dependent manner by modulating thiol/disulfide homeostasis in C6 glioblastoma cells. J Biochem Mol Toxicol 2021;35:e22742. [PMID: 33604990 DOI: 10.1002/jbt.22742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
36 Poonaki E, Ariakia F, Jalili-nik M, Shafiee Ardestani M, Tondro G, Samini F, Ghasemi S, Sahab-negah S, Gorji A. Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00078-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Duggan MR, Weaver M, Khalili K. PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging. Aging (Albany NY) 2021;13:1510-27. [PMID: 33472174 DOI: 10.18632/aging.202459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
38 Lo Dico A, Salvatore D, Diceglie C, Martelli C, Ottobrini L. Role of mitochondrial reactive oxygen species in glioblastoma drug resistance and strategies for therapeutic intervention. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021. [DOI: 10.1016/b978-0-12-821567-8.00026-9] [Reference Citation Analysis]
39 Ibarra LE, Vilchez ML, Caverzán MD, Milla Sanabria LN. Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events. J Neurosci Res 2021;99:1024-47. [PMID: 33370846 DOI: 10.1002/jnr.24776] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
40 Mishra VS, Kumar N, Raza M, Sehrawat S. Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme. Oncotarget 2020;11:4754-69. [PMID: 33473259 DOI: 10.18632/oncotarget.27842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Silva VCJD, Silva RNO, Colli LG, Carvalho MHC, Rodrigues SF. Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice. Heliyon 2020;6:e05591. [PMID: 33294714 DOI: 10.1016/j.heliyon.2020.e05591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Chang Y, Li G, Zhai Y, Huang L, Feng Y, Wang D, Zhang W, Hu H. Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma. Front Immunol 2020;11:580934. [PMID: 33329553 DOI: 10.3389/fimmu.2020.580934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
43 Grauers Wiktorin H, Aydin E, Hellstrand K, Martner A. NOX2-Derived Reactive Oxygen Species in Cancer. Oxid Med Cell Longev 2020;2020:7095902. [PMID: 33312338 DOI: 10.1155/2020/7095902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
44 Shin J, Saini RK, Oh JW. Low Dose Astaxanthin Treatments Trigger the Hormesis of Human Astroglioma Cells by Up-Regulating the Cyclin-Dependent Kinase and Down-Regulated the Tumor Suppressor Protein P53. Biomedicines 2020;8:E434. [PMID: 33086722 DOI: 10.3390/biomedicines8100434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
45 Jovanović M, Dragoj M, Zhukovsky D, Dar'in D, Krasavin M, Pešić M, Podolski-Renić A. Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy. Front Mol Biosci 2020;7:586146. [PMID: 33134322 DOI: 10.3389/fmolb.2020.586146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
46 Peleli M, Moustakas A, Papapetropoulos A. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies. Int J Mol Sci 2020;21:E7371. [PMID: 33036204 DOI: 10.3390/ijms21197371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
47 Caverzán MD, Beaugé L, Chesta CA, Palacios RE, Ibarra LE. Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status. J Photochem Photobiol B 2020;212:112045. [PMID: 33022469 DOI: 10.1016/j.jphotobiol.2020.112045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
48 Godoy PRDV, Pour Khavari A, Rizzo M, Sakamoto-Hojo ET, Haghdoost S. Targeting NRF2, Regulator of Antioxidant System, to Sensitize Glioblastoma Neurosphere Cells to Radiation-Induced Oxidative Stress. Oxid Med Cell Longev 2020;2020:2534643. [PMID: 32617133 DOI: 10.1155/2020/2534643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
49 Maccallini C, Gallorini M, Cataldi A, Amoroso R. Targeting iNOS As a Valuable Strategy for the Therapy of Glioma. ChemMedChem 2020;15:339-44. [PMID: 31851765 DOI: 10.1002/cmdc.201900580] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
50 Zhou Y, Wang L, Wang C, Wu Y, Chen D, Lee TH. Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas. Arch Pharm Res 2020;43:187-203. [PMID: 31956964 DOI: 10.1007/s12272-020-01205-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
51 Lo Dico A, Salvatore D, Martelli C, Ronchi D, Diceglie C, Lucignani G, Ottobrini L. Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma. Cells 2019;8:E1315. [PMID: 31653091 DOI: 10.3390/cells8111315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
52 Ghosh MK, Chakraborty D, Sarkar S, Bhowmik A, Basu M. The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports. Signal Transduct Target Ther 2019;4:42. [PMID: 31637020 DOI: 10.1038/s41392-019-0075-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
53 Barciszewska AM, Giel-Pietraszuk M, Perrigue PM, Naskręt-Barciszewska M. Total DNA Methylation Changes Reflect Random Oxidative DNA Damage in Gliomas. Cells 2019;8:E1065. [PMID: 31514401 DOI: 10.3390/cells8091065] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
54 Naletova I, Cucci LM, D'Angeli F, Anfuso CD, Magrì A, La Mendola D, Lupo G, Satriano C. A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours. Cancers (Basel) 2019;11:E1322. [PMID: 31500197 DOI: 10.3390/cancers11091322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
55 Ramírez-Expósito MJ, Martínez-Martos JM. The Delicate Equilibrium between Oxidants and Antioxidants in Brain Glioma. Curr Neuropharmacol 2019;17:342-51. [PMID: 29512467 DOI: 10.2174/1570159X16666180302120925] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
56 Zhang J, Wu J, Liu F, Tong L, Chen Z, Chen J, He H, Xu R, Ma Y, Huang C. Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review. Eur J Pharmacol 2019;858:172500. [PMID: 31238064 DOI: 10.1016/j.ejphar.2019.172500] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
57 McConnell DD, Carr SB, Litofsky NS. Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review. Expert Rev Neurother 2019;19:545-55. [PMID: 31092064 DOI: 10.1080/14737175.2019.1617701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
58 Öztürk Y, Günaydın C, Yalçın F, Nazıroğlu M, Braidy N. Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells. Oxid Med Cell Longev 2019;2019:4619865. [PMID: 30984336 DOI: 10.1155/2019/4619865] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
59 Pudełek M, Catapano J, Kochanowski P, Mrowiec K, Janik-Olchawa N, Czyż J, Ryszawy D. Therapeutic potential of monoterpene α-thujone, the main compound of Thuja occidentalis L. essential oil, against malignant glioblastoma multiforme cells in vitro. Fitoterapia 2019;134:172-81. [PMID: 30825580 DOI: 10.1016/j.fitote.2019.02.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
60 Yan Q. Stress and Systemic Inflammation: Yin-Yang Dynamics in Health and Diseases. Methods Mol Biol 2018;1781:3-20. [PMID: 29705839 DOI: 10.1007/978-1-4939-7828-1_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
61 Matschke V, Theiss C, Matschke J. Oxidative stress: the lowest common denominator of multiple diseases. Neural Regen Res 2019;14:238-41. [PMID: 30531003 DOI: 10.4103/1673-5374.244780] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
62 Deveci HA, Akyuva Y, Nur G, Nazıroğlu M. Alpha lipoic acid attenuates hypoxia-induced apoptosis, inflammation and mitochondrial oxidative stress via inhibition of TRPA1 channel in human glioblastoma cell line. Biomed Pharmacother 2019;111:292-304. [PMID: 30590317 DOI: 10.1016/j.biopha.2018.12.077] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
63 Rivera JF, Sridharan SV, Nolan JK, Miloro SA, Alam MA, Rickus JL, Janes DB. Real-time characterization of uptake kinetics of glioblastoma vs. astrocytes in 2D cell culture using microelectrode array. Analyst 2018;143:4954-66. [PMID: 30225487 DOI: 10.1039/c8an01198b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gupta K, Burns TC. Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications. Front Oncol 2018;8:503. [PMID: 30467536 DOI: 10.3389/fonc.2018.00503] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
65 Pedra NS, Galdino KCA, da Silva DS, Ramos PT, Bona NP, Soares MSP, Azambuja JH, Canuto KM, de Brito ES, Ribeiro PRV, Souza ASQ, Cunico W, Stefanello FM, Spanevello RM, Braganhol E. Endophytic Fungus Isolated From Achyrocline satureioides Exhibits Selective Antiglioma Activity-The Role of Sch-642305. Front Oncol 2018;8:476. [PMID: 30420941 DOI: 10.3389/fonc.2018.00476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
66 Privat-Maldonado A, Gorbanev Y, Dewilde S, Smits E, Bogaerts A. Reduction of Human Glioblastoma Spheroids Using Cold Atmospheric Plasma: The Combined Effect of Short- and Long-Lived Reactive Species. Cancers (Basel) 2018;10:E394. [PMID: 30360539 DOI: 10.3390/cancers10110394] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
67 Hoang-Minh LB, Siebzehnrubl FA, Yang C, Suzuki-Hatano S, Dajac K, Loche T, Andrews N, Schmoll Massari M, Patel J, Amin K, Vuong A, Jimenez-Pascual A, Kubilis P, Garrett TJ, Moneypenny C, Pacak CA, Huang J, Sayour EJ, Mitchell DA, Sarkisian MR, Reynolds BA, Deleyrolle LP. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma. EMBO J 2018;37:e98772. [PMID: 30322894 DOI: 10.15252/embj.201798772] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 18.3] [Reference Citation Analysis]
68 Palumbo P, Lombardi F, Siragusa G, Dehcordi SR, Luzzi S, Cimini A, Cifone MG, Cinque B. Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation. Int J Mol Sci 2018;19:E2801. [PMID: 30227679 DOI: 10.3390/ijms19092801] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
69 McConnell DD, McGreevy JW, Williams MN, Litofsky NS. Do Anti-Oxidants Vitamin D3, Melatonin, and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells? Medicines (Basel) 2018;5:E58. [PMID: 29925764 DOI: 10.3390/medicines5020058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
70 da Nóbrega FR, Ozdemir O, Nascimento Sousa SCS, Barboza JN, Turkez H, de Sousa DP. Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma. Molecules 2018;23:E1382. [PMID: 29890617 DOI: 10.3390/molecules23061382] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
71 Xing Z, Ni Y, Zhao J, Ma X. Hydrogen Peroxide-Induced Secreted Frizzled-Related Protein 1 Gene Demethylation Contributes to Hydrogen Peroxide-Induced Apoptosis in Human U251 Glioma Cells. DNA and Cell Biology 2017;36:347-53. [DOI: 10.1089/dna.2016.3594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
72 Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Front Cell Dev Biol 2017;5:43. [PMID: 28491867 DOI: 10.3389/fcell.2017.00043] [Cited by in Crossref: 171] [Cited by in F6Publishing: 188] [Article Influence: 34.2] [Reference Citation Analysis]
73 Soon BH, Abdul Murad NA, Then SM, Abu Bakar A, Fadzil F, Thanabalan J, Mohd Haspani MS, Toh CJ, Mohd Tamil A, Harun R, Wan Ngah WZ, Jamal R. Mitochondrial DNA Mutations in Grade II and III Glioma Cell Lines Are Associated with Significant Mitochondrial Dysfunction and Higher Oxidative Stress. Front Physiol 2017;8:231. [PMID: 28484394 DOI: 10.3389/fphys.2017.00231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
74 Gomes AC, Mello AL, Ribeiro MG, Garcia DG, Da Fonseca CO, Salazar MD, Schönthal AH, Quirico-santos T. Perillyl alcohol, a pleiotropic natural compound suitable for brain tumor therapy, targets free radicals. Arch Immunol Ther Exp 2017;65:285-97. [DOI: 10.1007/s00005-017-0459-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
75 Watts FZ. Repair of DNA Double-Strand Breaks in Heterochromatin. Biomolecules 2016;6:E47. [PMID: 27999260 DOI: 10.3390/biom6040047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
76 Mazzio EA, Bauer D, Mendonca P, Taka E, Soliman KF. Natural product HTP screening for attenuation of cytokine-induced neutrophil chemo attractants (CINCs) and NO2- in LPS/IFNγ activated glioma cells. J Neuroimmunol 2017;302:10-9. [PMID: 27956075 DOI: 10.1016/j.jneuroim.2016.11.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
77 Ivanova D, Zhelev Z, Aoki I, Bakalova R, Higashi T. Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugs. Chin J Cancer Res 2016;28:383-96. [PMID: 27647966 DOI: 10.21147/j.issn.1000-9604.2016.04.01] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
78 Stojković S, Podolski-Renić A, Dinić J, Pavković Ž, Ayuso JM, Fernández LJ, Ochoa I, Pérez-García VM, Pešić V, Pešić M. Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model. Molecules 2016;21:E843. [PMID: 27355941 DOI: 10.3390/molecules21070843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]